POMC and neoplasm: ACTH-secreting neoplasms present several receptors, especially SSTRs, the target of theranostic somatostatin-based diagnosis (with octreoscan 68Ga-SSTR-PET/CT (10, 13, 14)) or treatment (with somatostatin analogs (15, 16)).